News
- Author:
- Neil Osterweil
Publish date: October 4, 2023
Stereotactic radiosurgery was better at preventing loss of verbal recall function at 3 months than whole-brain radiation therapy, the current stand...
News
- Author:
- Neil Osterweil
Publish date: October 4, 2023
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam ...
News
- Author:
- Neil Osterweil
Publish date: October 4, 2023
“The findings suggest that children, adolescents, and young adults with low-risk relapsed classic Hodgkin lymphoma can be salvaged with low-toxicit...
News
- Author:
- Neil Osterweil
Publish date: September 13, 2023
Recent data presented at SOHO 2023 suggested that adding brentuximab vedotin to chemotherapy for Hodgkin lymphoma improves outcomes, even without P...
News
- Author:
- Neil Osterweil
Publish date: September 11, 2023
The issue of whether or not patients with r/r AML require additional treatment pretransplant was debated at SOHO 2023.
News
- Author:
- Neil Osterweil
Publish date: August 30, 2023
“The idea is that this could be used as kind of a first-pass screening tool for patients with hematuria that could potentially obviate the need for...
News
- Author:
- Neil Osterweil
Publish date: July 28, 2023
“In the ethical design of clinical trials, patients make important sacrifices to participate, and in exchange, the academic and clinical communitie...
News
- Author:
- Neil Osterweil
Publish date: July 12, 2023
Private equity offers the allure of financial and administrative stability.
News
- Author:
- Neil Osterweil
Publish date: July 6, 2023
Physical frailty, disabilities, and multimorbidities increase the risk for adverse outcomes among elderly patients with obstructive airways disease...
News
- Author:
- Neil Osterweil
Publish date: June 23, 2023
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority g...
News
- Author:
- Neil Osterweil
Publish date: June 23, 2023
Few patients with cancer have access to psycho-oncologic support.
News
- Author:
- Neil Osterweil
Publish date: June 23, 2023
T-DXd is a potential new treatment option for patients with HER2-expressing solid tumors, experts say.
News
- Author:
- Neil Osterweil
Publish date: June 23, 2023
“Early CAR Ts demonstrating efficacy and safety and prior lines of treatment impact survival from CAR T in myeloma. Can this also be true for multi...
News
- Author:
- Neil Osterweil
Publish date: June 20, 2023
The PREACH-M trial has yielded encouraging preliminary results in treating CMML, a rare, “insidious” leukemia that can transform into AML.
News
- Author:
- Neil Osterweil
Publish date: June 15, 2023
“Do we absolutely have to do a mastectomy for a patient who has a second episode of cancer in the same breast? The answer is no.”
